美国2018年的狂犬病监测

（十）2019年资料更新和参考文献

(题目为Rabies surveillance in the United States during 2018（美国2018年的狂犬病监测）的研究论文发表在J Am Vet Med Assoc（美国兽医协会杂志） 2020;256:195–208.)

2019年狂犬病资料更新

从2019年1月到9月，美国没有报告人类狂犬病病例。近年来出现了两种新的预防人类狂犬病毒感染的人类狂犬病免疫球蛋白产品。由Kamada有限公司生产的KEDRAB于2017年8月获得FDA许可用于PEP方案。HYPERRAB则由Grifols Therapeutics LLC公司生产，于2018年2月获得FDA批准。HYPERRAB与以前授权的HYPERRAB S/D的区别在于它的效力是后者的两倍(分别为300U /mL和150U /mL)。所有人类狂犬病免疫球蛋白制品的推荐使用剂量为20 -U /kg (或9.1-U/lb)，因此使用HYPERRAB时只需要更小的体积。卫生保健提供者应在给药前核实人类狂犬病免疫球蛋白的正确剂量，以确保按照建议给药。

Acknowledgments（声明和致谢）

The authors declare that there were no conflicts of interest. Use of trade names and commercial sources is for identification only and does not imply endorsement by the US Department of Health and Human Services. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the CDC.

The authors thank the state and territorial health and agriculture departments and laboratories for their contributions of rabies surveillance data and human case investigations. The authors also thank the staff of the CDC Poxvirus and Rabies Branch for their help and support.

References（参考文献）

1.  Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis 2015;9:e0003709.

2.  World Health Organization. WHO expert consultation on rabies: second report. WHO Technical Report Series, No. 982. Geneva: World Health Organization, 2013.

3.  Wallace RM, Gilbert A, Slate D, et al. Right place, wrong species: a 20-year review of rabies virus cross-species transmission among terrestrial mammals in the United States. PLoS One 2014; 9: e107539.

4.  Streicker DG, Turmelle AS, Vonhof MJ, et al. Host phylogeny constrains cross-species emergence and establishment of rabies virus in bats. Science 2010;329:676–679.

5.  Kuzmina NA, Kuzmin IV, Ellison JA, et al. A reassessment of the evolutionary timescale of bat rabies viruses based upon glycoprotein gene sequences. Virus Genes 2013;47:305–310.

6.  Pieracci EG, Pearson CM, Wallace RM, et al. Vital signs: trends in human rabies deaths and exposures—United States, 1938–2018. MMWR Morb Mortal Wkly Rep 2019;68:524–528.

7.  Petersen BW, Rupprecht CE. Human rabies epidemiology and diagnosis. In: Thacker S, ed. Non-flavivirus encephalitis. Rjeka, Croatia: InTech, 2011;247–278.

8.  CDC. Imported human rabies—California, 2008. MMWR Morb Mortal Wkly Rep 2009;58:713–716.

9.  Rupprecht CE, Briggs D, Brown CM, et al. Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2010;59:1–9.

10. Brown CM, Slavinski S, Ettestad P, et al. Compendium of animal rabies prevention and control, 2016 (Erratum published in J Am Vet Med Assoc 2016;248:771). J Am Vet Med Assoc 2016; 248: 505–517.

11. Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention—United States, 2008: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2008;57:1–28.

12. Davis AD, Dupuis M, Rudd RJ. Extended incubation period of rabies virus in a captive big brown bat (Eptesicus fuscus). J Wildl Dis 2012;48:508–511.

13. Slate D, Algeo TP, Nelson KM, et al. Oral rabies vaccination in North America: opportunities, complexities, and challenges. PLoS Negl Trop Dis 2009;3:e549.

14. Sidwa TJ, Wilson PJ, Moore GM, et al. Evaluation of oral rabies vaccination programs for control of rabies epizootics in coyotes and gray foxes: 1995–2003. J Am Vet Med Assoc 2005; 227: 785–792.

15. National Notifiable Diseases Surveillance System. 2017 nationally notifiable conditions. Available at: wwwn.cdc.gov/nndss/conditions/notifiable/2017/. Accessed Jan 30, 2017.

16. Ronald G, Powell J, Raj P, et al. Protocol for postmortem diagnosis of rabies in animals by direct fluorescent antibody testing: a minimum standard for rabies diagnosis in the United States. Atlanta: CDC, 2003. Available at: www.cdc.gov/rabies/pdf/rabiesdfaspv2.pdf. Accessed Jan 30, 2017.

17.  Lembo T, Niezgoda M, Velasco-Villa A, et al. Evaluation of a direct, rapid immunohistochemical test for rabies diagnosis. Emerg Infect Dis 2006;12:310–313.

18. Blanton JD, Robertson K, Palmer D, et al. Rabies surveillance in the United States during 2008. J Am Vet Med Assoc  2009; 235: 676–689.

19. Council for State and Territorial Epidemiologists. CSTE list of nationally notifiable conditions, August 2012. Available at:  cdn.ymaws.com/www.cste.org/resource/resmgr/PDFs/CSTENotifiableConditionListA.pdf. Accessed Oct 1, 2019.

20. Canadian Food Inspection Agency. Rabies cases in Canada—2017.  Available  at:  www.inspection.gc.ca/animals/terrestrial-animals/diseases/reportable/rabies/2018-rabies-in-canada/eng/1550860268670/1550860329289. Accessed Sep 24, 2019.

21. Krebs JW, Strine TW, Smith JS, et al. Rabies surveillance in the United States during 1993. J Am Vet Med Assoc 1994;205:1695–1709.

22. Dyer JL, Yager P, Orciari LA, et al. Rabies surveillance in the United States during 2013 (Erratum published in J Am Vet Med Assoc 2014;245:1358). J Am Vet Med Assoc 2014;245:1111–1123.

23. USDA APHIS Wildlife Services. National Rabies Management Program: FY2018 ORV distribution summary. Available at: www.aphis.usda.gov/wildlife_damage/oral_rabies/orv_by_state/US/reports/FY2018_US.pdf. Accessed Dec 16, 2019.

24. Rupprecht CE, Blass L, Smith K, et al. Human infection due to recombinant vaccinia-rabies glycoprotein virus. N Engl J Med 2001;345:582–586.

25. CDC. Human vaccinia infection after contact with a raccoon rabies vaccine bait—Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep 2009;58:1204–1207.

26. Lobo D, DeBenedet C, Fehlner-Gardiner C, et al. Raccoon rabies outbreak in Hamilton, Ontario: a progress report. Can Commun Dis Rep 2018;44:116–121.

27. Christian KA, Blanton JD, Auslander M, et al. Epidemiology of rabies post-exposure prophylaxis United States of America, 2006–2008. Vaccine 2009;27:7156–7161.

28. Davis AJ, Kirby JD, Chipman RB, et al. Not all surveillance data are created equal—a multi-method dynamic occupancy approach to determine rabies elimination from wildlife. J Appl Ecol  2019; 56: 2551–2561.

29. Manning SE, Rupprecht CE, Fishbein D, et al. Human rabies prevention—United States, 2008: recommendations of the Advisory Committee on Immunization Practices. Available at: www.cdc.gov/mmwr/preview/mmwrhtmL/rr5703a1.htm.  Accessed Oct 1, 2019.

相关博文：

美国2018年的狂犬病监测（一）概要  2020-02-14 

美国2018年的狂犬病监测（二）序言  2020-02-17

美国2018年的狂犬病监测（三） 样品报告、测试和分析  2020-02-18

美国2018年的狂犬病监测（四）野生动物中的狂犬病   2020-02-19

美国2018年的狂犬病监测（四）野生动物中的狂犬病(2-5) 2020-02-20

美国2018年的狂犬病监测（五）家养动物中的狂犬病 2020-02-21

美国2018年的狂犬病监测（六）人类狂犬病 2020-02-22

美国2018年的狂犬病监测 （七）美国的狂犬病控制项目 2020-02-23

美国2018年的狂犬病监测 （八）加拿大和墨西哥的狂犬病 2020-02-24

美国2018年的狂犬病监测（九）讨论1 2020-02-25

美国2018年的狂犬病监测（九）讨论 2 2020-02-26

原论文全文下载：

Rabies surveillance in the United States during 2018.pdf